---

Related Articles:

Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.

2014-08-01

[J. Infect. Dis. 210(3) , 456-66, (2014)]

Application of permeability-limited physiologically-based pharmacokinetic models: part II - prediction of P-glycoprotein mediated drug-drug interactions with digoxin.

2013-09-01

[J. Pharm. Sci. 102(9) , 3161-73, (2013)]

Stereoselective CZE method for analysis of verapamil and norverapamil in human plasma.

2013-01-01

[Acta Pol. Pharm. 70(3) , 395-401, (2013)]

The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog.

1983-01-01

[Pharmacology 27 , 1-8, (1983)]

Physiological pharmacokinetics and pharmacodynamics of (+/-)-verapamil in female rats.

1987-01-01

[Biopharm. Drug Dispos. 8 , 285, (1987)]